Company: PSTV
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001140361-25-013256
Chunk: 24

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 24
---
.98 per share of Common Stock or pursuant to a zero exercise price provision. The Series B Warrants are exercisable only if the Warrant Stockholder Approval is obtained and expire two and one-half (2.5) years thereafter. The Series B Warrant exercise price and the related number of shares of Common Stock issuable upon exercise are subject to a “reset” provision upon certain events, as more fully described in the Series A Warrant, and the Series B Warrant zero exercise price provision provides that the Series B Warrant can be exercised without further payment to the Company and for three times the number of shares of Common Stock issuable upon exercise of the Series B Warrants for cash. The Private Placement closed on March 4, 2025, at which time the proceeds were deposited into an escrow account and thereafter released on March 10, 2025, following Nasdaq’s confirmation that the Company had demonstrated compliance with Nasdaq’s minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1). The net proceeds to the Company from the Private Placement were approximately $13,276,749 (after deducting certain fees and the payment of other offering expenses associated with the Private Placement that were payable by the Company). The following summary of certain terms and provisions of the Warrants is not complete and is subject to and qualified in its entirety by the provisions of the forms of Warrants which were filed as exhibits 4.1 and 4.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 4, 2025. Exercisability . The Prefunded Warrants are exercisable at any time after their original issuance until they are exercised in full. The Series A Warrants will be exercisable only if the Warrant Stockholder Approval is obtained and expire five (5) years after the Warrant Stockholder Approval, and the Series B Warrants will be exercisable only if the Warrant Stockholder Approval is obtained and expire two and one half (2.5) years thereafter if the Warrant Stockholder Approval is obtained. Each of the Warrants and the Prefunded Warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice accompanied by payment in full in immediately available funds for the number of shares of Common Stock subscribed for upon such exercise (except in the case of a cashless exercise or zero exercise price as discussed below).

14

####